XML 84 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Financial Statements of Parent Company (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Statements of Parent Company  
Schedule of condensed balance sheet

December 31,

 

(Dollars in thousands)

2023

2022

 

ASSETS

    

    

    

    

Cash

$

110,001

$

89,069

Investment in subsidiaries

 

5,808,108

 

5,368,525

Other assets

 

10,016

 

12,555

Total assets

$

5,928,125

$

5,470,149

LIABILITIES AND SHAREHOLDERS’ EQUITY

Corporate and subordinated debentures

$

391,904

$

392,275

Other Liabilities

3,123

2,947

Shareholders’ equity

 

5,533,098

 

5,074,927

Total liabilities and shareholders’ equity

$

5,928,125

$

5,470,149

Schedule of condensed statements of income

Year Ended December 31,

 

(Dollars in thousands)

2023

2022

2021

 

Income:

    

    

    

    

    

    

Dividends from subsidiaries

$

180,251

$

220,124

$

200,083

Operating (loss) income

 

1

 

(68)

 

25

Total income

 

180,252

 

220,056

 

200,108

Operating expenses

 

39,151

 

30,514

 

40,727

Income before income tax benefit and equity in undistributed earnings of subsidiaries

 

141,101

 

189,542

 

159,381

Applicable income tax benefit

 

8,177

 

6,649

 

9,053

Equity in undistributed earnings of subsidiaries

 

345,030

 

299,858

 

307,109

Net income available to common shareholders

$

494,308

$

496,049

$

475,543

Schedule of condensed statements of cash flows

Year Ended December 31,

 

(Dollars in thousands)

2023

2022

2021

 

Cash flows from operating activities:

    

    

    

    

    

    

Net income

$

494,308

$

496,049

$

475,543

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

 

(371)

 

(208)

 

1,382

Share-based compensation

 

35,861

 

35,638

 

25,721

Extinguishment of debt cost

11,706

Decrease (increase) in other assets

 

2,539

 

(375)

 

5,690

(Decrease) increase in other liabilities

 

175

 

(243)

 

(3,648)

Undistributed earnings of subsidiaries

 

(345,030)

 

(299,858)

 

(307,109)

Net cash provided by operating activities

 

187,482

 

231,003

 

209,285

Cash flows from investing activities:

Repayment of investments in and advances to subsidiaries

93,591

Net cash inflow from acquisitions

 

 

51,566

 

Net cash provided by investing activities

 

 

51,566

 

93,591

Cash flows from financing activities:

Proceeds of other borrowings

100

Repayment of other borrowings

 

(100)

 

(13,000)

 

(75,878)

Common stock issuance

 

2,772

 

2,858

 

2,384

Common stock repurchased

 

(16,064)

 

(119,330)

 

(147,421)

Dividends paid on common stock

 

(156,184)

 

(146,664)

 

(135,337)

Stock options exercised

 

2,926

 

1,585

 

2,905

Net cash used in financing activities

 

(166,550)

 

(274,551)

 

(353,347)

Net (decrease) increase in cash and cash equivalents

 

20,932

 

8,018

 

(50,471)

Cash and cash equivalents at beginning of period

 

89,069

 

81,051

 

131,522

Cash and cash equivalents at end of period

$

110,001

$

89,069

$

81,051